Cardinal Health clears a fresh record, shares extend the strong run on NYSE
25.06.2026 - 17:38:06 | ad-hoc-news.de
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 17:37.
Cardinal Health (US14149Y1082) has pushed to a new all-time high around 233 to 235 US dollars this week. The shares trade on the NYSE and recently touched a 52-week peak in the 233 to 236 dollar range, according to recent data from Investing.com and other price services Investing.com report on the record level.
What the latest numbers show
The immediate backdrop to the new high is a robust fiscal third quarter 2026. Cardinal Health reported adjusted earnings per share of 3.17 US dollars, clearly above the consensus expectation of 2.79 dollars, as summarized by Investing.com Investing.com coverage of Q3 results. Revenue in the quarter reached about 61.0 billion dollars, slightly below the 62.11 billion dollars that analysts had forecast, which indicates pressure on top-line growth even as profitability improved.
Management nevertheless raised its outlook after the quarter, signaling confidence in the earnings trajectory through the remainder of the fiscal year StockTitan summary of outlook and events. The company also approved a higher quarterly dividend of roughly 0.5158 dollars per share, with a record date on 1 July 2026 and payment scheduled for 15 July 2026, underlining a continued emphasis on shareholder returns Investing.com dividend and outlook details.
Chart picture and analyst signals
On the technical side, Cardinal Health shares trade comfortably above their 50-day and 200-day moving averages, with one data service putting those supports around 204 dollars and 198 dollars respectively PandaForecast summary of key moving averages. That places the stock well into an established uptrend, around 15 to 20 percent above key medium-term support levels.
Technical screens currently show a cluster of buy signals. TradingKey, which tracks indicators such as moving averages and momentum oscillators, reports that Cardinal Health has four buy signals versus one sell, and that all six major moving-average signals from 5-day to 200-day are in buy territory TradingKey technical analysis on Cardinal Health. The service also notes a price momentum score above 9 out of 10, placing the shares near the top of its pharmaceuticals and healthcare distribution universe by relative strength.
All news and analysis on the Cardinal Health shares
Price data, corporate releases and further reporting on Cardinal Health are collected on the dedicated topic page and in the company’s Investor Relations section.
How Cardinal Health earns its money
Cardinal Health’s core business is large-scale healthcare distribution and related services. The company is one of the three major pharmaceutical distributors in the United States, alongside McKesson and AmerisourceBergen, and supplies branded and generic drugs to hospitals, pharmacies and other care providers MarketBeat company overview for Cardinal Health. It also distributes medical and surgical products to hospitals and clinics, and operates its own Cardinal Health brand in areas such as gloves, surgical drapes and nutritional products, giving it a broad, recurring-revenue base.
Where the shares trade today
The Cardinal Health shares (US14149Y1082) last traded on the NYSE at 234.64 US dollars on 2026-06-25, 09:43 Eastern Time, based on data from StockTitan and other quote services. This price implies a market capitalization of around 53.6 billion US dollars for the healthcare distributor StockTitan price and market capitalization snapshot.
Key data on the Cardinal Health shares
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- WKN: 879312
- Ticker: CAH
- Trading venue: NYSE
- Price (as of 2026-06-25, 09:43): 234.64 USD
- Market cap: 53.6 billion USD (as of 2026-06-25)
- Sector / industry: Health care distributors / medical distribution
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions.
